In aSAH, CGRP has been demonstrated to be excessively released into cerebrospinal fluid (CSF) [31, 33] with a potential neuroprotective effect by preventing CV and cerebral ischemia [33]. The gene discussed is CALCA; the disease is brain ischemia.